For Valbenazine, what is the recommended dose for acute dystonia administered via IM/IV?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $24.99Unlock all

Master HIV/AIDS Antiretroviral Therapy Test with comprehensive flashcards and multiple-choice questions. Each question provides detailed explanations to enhance your knowledge. Prepare effectively and excel in your exam!

Multiple Choice

For Valbenazine, what is the recommended dose for acute dystonia administered via IM/IV?

Explanation:
Valbenazine is a VMAT2 inhibitor used to treat tardive dyskinesia and is taken orally. It does not have an approved intramuscular or intravenous formulation, and its therapeutic effect for tardive dyskinesia develops over days, not in minutes. Acute dystonia requires rapid relief with a fast-acting, parenteral agent such as benztropine or diphenhydramine. Therefore there is no recommended IM/IV dose for valbenazine in acute dystonia. In practice, manage acute dystonia with quick-acting parenteral anticholinergics, and use valbenazine as the chronic oral treatment for tardive dyskinesia.

Valbenazine is a VMAT2 inhibitor used to treat tardive dyskinesia and is taken orally. It does not have an approved intramuscular or intravenous formulation, and its therapeutic effect for tardive dyskinesia develops over days, not in minutes. Acute dystonia requires rapid relief with a fast-acting, parenteral agent such as benztropine or diphenhydramine. Therefore there is no recommended IM/IV dose for valbenazine in acute dystonia. In practice, manage acute dystonia with quick-acting parenteral anticholinergics, and use valbenazine as the chronic oral treatment for tardive dyskinesia.

More Multiple Choice Questions
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy